期刊文献+

HBX在肝癌细胞中通过下调miR-199a增强AKT的表达 被引量:1

HBX enhances AKT expression through down-regulation of miR-199a in hepatitis B virus related hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨乙型肝炎病毒X蛋白(hepatitis B virus X protein,HBX)调节miR-199a的表达在HBV相关性肝癌发生中的分子机制。方法重组HBX腺病毒(Ad-HBX)感染人肝癌Hep G2细胞,HBX的siRNA转染稳定表达HBV基因的人肝癌Hep G2.2.15细胞,荧光定量PCR方法检测HBV相关性肝癌组织标本和肝癌细胞中HBX、miR-199a、AKT的mRNA表达水平及运用Western blot检测肝癌组织标本和肝癌细胞中HBX、AKT的蛋白表达水平;分别用miR-199a mimics和miR-199a inhibitor的转染肝癌细胞后,荧光定量PCR方法检测肝癌细胞中AKT的mRNA表达水平及运用Western blot检测肝癌细胞中AKT的蛋白表达水平。结果 miR-199a在Hep G2.2.15细胞中表达水平显著低于Hep G2细胞,并且证实其表达下调受到了HBX的调控(P<0.05),Hep G2.2.15细胞中AKT表达水平显著高于Hep G2细胞(P<0.05),在Hep G2.2.15细胞中过表达miR-199a能明显下调AKT表达水平以及在Hep G2细胞中抑制miR-199a能明显上调的AKT表达水平(P<0.05),此外,miR-199a的表达量在HBV相关性肝癌组织比相应的癌旁组织表达降低。结论 HBX可以通过miR-199a调节AKT导致HBV相关性肝癌发生。 Objective To explore the potential mechanism of hepatitis B virus X protein (HBX) - modulated miR-199a expression in hepatitis B virus (HBV) related hepatocarcinogenesis. Methods HepG2 cells were transfected with HBX-containing recombinant adenovirus (Ad-HBX), and HepG2. 2. 15 cells capable of stably expressing HBV gene were transfected with siRNA-HBX. Fluorescence quantitative PCR was used for detecting mRNA expression levels of HBX, miR-199a, and AKT in HBV-related hepatocellular carcinoma tissues and hepatocellular carcinoma cells, while Western blotting was adopted to detect the protein expression of HBX and AKT. After transfection with miR-199a mimics and miR-199a inhibitor, quantitative PCR and Western blotting were employed to detect the expression of AKT in hepatocellular carcinoma ceils. Results Experimental results showed that miR-199a expression in HepG2.2.15 cells was significantly lower than that in HepG2 cells, and down-regulation of miR-199a expression was related with HBX ( P 〈 0. 05 ). AKT expression in HepG2.2.15 cells was significantly higher than that in HepG2 ceils (P 〈 0. 05 ), and over- expression of miR-199a in HepG2. 2.15 cells could significantly reduce AKT expression ( P 〈 0. 05 ), while inhibition of miR-199a in HepG2 cells could significantly increase AKT expression (P 〈0.05 ). In addition, the expression level of miR-199a in HBV-related hepatocellular carcinoma tissues was lower than that in the adjacent noncancer tissues. Conclusion HBX regulates the AKT expression through miR-199a, which may lead to HBV-related hepatocarcinogenesis.
作者 谌玲 谭翠
出处 《第三军医大学学报》 CAS CSCD 北大核心 2015年第10期996-1000,共5页 Journal of Third Military Medical University
基金 国家自然科学基金(81171562)~~
关键词 乙型肝炎病毒X蛋白 微小RNA 肝癌 AKT信号通路 hepatitis B virus X miR-199a hepatocellular cancer AKT signal pathway
  • 相关文献

参考文献17

  • 1Jemal A, Bray F, Center M M, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
  • 2Wang Y, Cui F, Lv Y, et al. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice[J]. Hepatology, 2004, 39(2): 318-324.
  • 3Tan A, Yeh S H, Liu C J, et al. Viral hepatocarcinogenesis: from infection to cancer[J]. Liver Int, 2008, 28(2): 175-188.
  • 4Cao J X, Lu Y, Qi J J, et al. MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells[J]. Cell Death Dis, 2014, 5: e1426.
  • 5Jiang J, Zhang Y, Yu C, et al. MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN[J]. Cancer Cell Int, 2014, 14(1): 95.
  • 6Cheung H H, Davis A J, Lee T L, et al. Methylation of an intronic region regulates miR-199a in testicular tumor malignancy[J]. Oncogene, 2011, 30(31): 3404-3415.
  • 7Han Y, Kuang Y, Xue X, et al. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer[J]. Biomed Pharmacother, 2014, 68(5): 497-505.
  • 8Zhang J, Wu G Q, Zhang Y, et al. Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression[J]. Cell Biol Int, 2013, 37(3): 227-232.
  • 9Zhang Z, Hou X, Shao C, et al. Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer[J]. Cancer Res, 2014, 74(22): 6635-6647.
  • 10Zhang W, Liu S, Liu K, et al. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo[J]. Oncol Rep, 2014, 32(5): 1913-1922.

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部